The Health News USA May 10 2018

EpiPen has been recently added to the US Food and Drug Administration’s list of drug shortages due to manufacturing delays. Generic versions of Epipen along with Adrenaclick autoinjectors are all medications used to treat allergic reactions, some of which can be life-threatening.

The autoinjector allergy drug EpiPen has been recently added to the US Food and Drug Administration’s list of drug shortages due to manufacturing delays. Generic versions of Epipen along with Adrenaclick autoinjectors are all medications used to treat allergic reactions, some of which can be life-threatening. These absolute necessities for children suffering from severe allergies to counter effects such as increased or decreased heart rate, uneven breathing, swelling and other potentially fatal reactions.

The drug is distributed by Mylan but it is manufactured by a Pfizer company called Meridian Medical Technologies. However Mylan stated in a press release: “The product is available and Mylan is currently receiving continual supply from its manufacturing partner.” The company explained they are accelerating the shipment of EpiPens to wholesalers and supply levels may vary across wholesalers and pharmacies.

Pfizer said in a press release it is working to increase production of the medications as quickly as possible. The company has already asked that customers with a “medically appropriate” supply of unexpired EpiPen to be sensible when it comes to refilling additional prescriptions during the shortage so others can access the drug.

Liked it? Take a second to support healthprofessionalradio on Patreon!

0 Comments

Leave a Reply

You must be logged in to post a comment.